HEALTH Secretary Ted Herbosa cautioned the public against the use of intravenous (IV) glutathione that has not received approval from the Food and Drug Administration (FDA).
“IV glutathione may promise skin whitening and a ‘Caucasian’ appearance, but it poses severe risks, including potential kidney damage and even fatal outcomes,” Herbosa emphasized during a media forum held on Wednesday.
Herbosa clarified that IV glutathione is intended for use in hospitals as a rescue medicine for complications arising from chemotherapy in cancer patients.
“From the perspective of the Department of Health, it is not a safe practice. The FDA has not approved for its use in skin whitening. Any utilization of such products is deemed illegal,” reiterated the Health Secretary.
Highlighting a tragic incident, Herbosa shared details about a 36-year-old woman who reportedly lost her life after undergoing glutathione and stem cell intravenous infusion at a clinic in Quezon City.
“The loss of a life that could have been prevented is a poignant reminder. Immediate action is required to address such incidents,” stressed Herbosa.
